Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skin Protectant Chafing Claims Requested In CTFA Petition

This article was originally published in The Tan Sheet

Executive Summary

The Cosmetic, Toiletry & Fragrance Association requests that chafing indications be reinstated in the OTC Skin Protectant Drug Products Final Monograph in a July 7 petition to FDA. The claims previously were included in the tentative final monograph for the category

You may also be interested in...



Antiperspirant Duration Claims Limit Revision Sought By CTFA

FDA should revoke the provision in the OTC Antiperspirant Drug Products Final Monograph limiting duration of efficacy claims to 24 hours, the Cosmetic, Toiletry & Fragrance Association contends in a July 8 petition to the agency

Antiperspirant Duration Claims Limit Revision Sought By CTFA

FDA should revoke the provision in the OTC Antiperspirant Drug Products Final Monograph limiting duration of efficacy claims to 24 hours, the Cosmetic, Toiletry & Fragrance Association contends in a July 8 petition to the agency

Colloidal Oatmeal Among 19 Actives Cleared By Skin Protectant Monograph

FDA's OTC Skin Protectant Final Monograph designates colloidal oatmeal Category I for the indication, "temporarily protects and helps relieve minor skin irritation and itching due to: rashes, eczema, poison ivy, oak or sumac, insect bites." The rule was released June 4

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel